Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

The impact of treatment allocation procedures on nominal significance levels and bias.

Kalish LA, Begg CB.

Control Clin Trials. 1987 Jun;8(2):121-35.

PMID:
3608506
2.

Treatment allocation for nonlinear models in clinical trials: the logistic model.

Begg CB, Kalish LA.

Biometrics. 1984 Jun;40(2):409-20.

PMID:
6487725
3.

Properties of permuted-block randomization in clinical trials.

Matts JP, Lachin JM.

Control Clin Trials. 1988 Dec;9(4):327-44.

PMID:
3203524
4.

Properties of simple randomization in clinical trials.

Lachin JM.

Control Clin Trials. 1988 Dec;9(4):312-26.

PMID:
3203523
5.

On design considerations and randomization-based inference for community intervention trials.

Gail MH, Mark SD, Carroll RJ, Green SB, Pee D.

Stat Med. 1996 Jun 15;15(11):1069-92. Review.

PMID:
8804140
6.

Statistical properties of randomization in clinical trials.

Lachin JM.

Control Clin Trials. 1988 Dec;9(4):289-311. Review.

PMID:
3060315
7.

Properties of the urn randomization in clinical trials.

Wei LJ, Lachin JM.

Control Clin Trials. 1988 Dec;9(4):345-64. Erratum in: Controlled Clin Trials 1989 Mar;10(1):following 126.

8.

A group sequential, response-adaptive design for randomized clinical trials.

Karrison TG, Huo D, Chappell R.

Control Clin Trials. 2003 Oct;24(5):506-22. Review.

PMID:
14500050
9.

The method of minimization for allocation to clinical trials. a review.

Scott NW, McPherson GC, Ramsay CR, Campbell MK.

Control Clin Trials. 2002 Dec;23(6):662-74. Review.

PMID:
12505244
10.

Statistical comparison of random allocation methods in cancer clinical trials.

Hagino A, Hamada C, Yoshimura I, Ohashi Y, Sakamoto J, Nakazato H.

Control Clin Trials. 2004 Dec;25(6):572-84.

PMID:
15588744
11.

Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.

Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G.

Health Technol Assess. 2001;5(33):1-56. Review.

12.

Generalized multidimensional dynamic allocation method.

Lebowitsch J, Ge Y, Young B, Hu F.

Stat Med. 2012 Dec 10;31(28):3537-44. doi: 10.1002/sim.5418. Epub 2012 Jun 27.

PMID:
22736449
13.

Adaptive allocation in randomized controlled trials.

Birkett NJ.

Control Clin Trials. 1985 Jun;6(2):146-55.

PMID:
4006488
14.

Treatment allocation methods in clinical trials: a review.

Kalish LA, Begg CB.

Stat Med. 1985 Apr-Jun;4(2):129-44. Review.

PMID:
3895341
15.

Using permutation tests and bootstrap confidence limits to analyze repeated events data from clinical trials.

Freedman L, Sylvester R, Byar DP.

Control Clin Trials. 1989 Jun;10(2):129-41.

PMID:
2752763
17.

Designing for cancer clinical trials: selection of prognostic factors.

Brown BW Jr.

Cancer Treat Rep. 1980 Feb-Mar;64(2-3):499-502.

PMID:
7407790
18.

Advantages of permutation (randomization) tests in clinical and experimental pharmacology and physiology.

Ludbrook J.

Clin Exp Pharmacol Physiol. 1994 Sep;21(9):673-86. Review.

PMID:
7820947
19.
20.

Imbalance in treatment assignments in stratified blocked randomization.

Hallstrom A, Davis K.

Control Clin Trials. 1988 Dec;9(4):375-82.

PMID:
3203527

Supplemental Content

Support Center